KALLEY HEADLEY: Open Payments
NPI 1659843803 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,828 in 73 payments from 17 companies in 2025. Trend: 2023 $1,768 · 2024 $2,363 · 2025 $1,828
Food & beverage: $1,729Education: $100
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 4 | $278 |
| Novartis Pharmaceuticals Corporation | 10 | $247 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $199 |
| Janssen Biotech, Inc. | 7 | $150 |
| Incyte Corporation | 5 | $120 |
| Amgen Inc. | 5 | $118 |
| UCB, Inc. | 5 | $112 |
| ABBVIE INC. | 5 | $106 |
| GENZYME CORPORATION | 3 | $99 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
Products named: Zoryve, COSENTYX, TREMFYA, OPZELURA, DUPIXENT, OTEZLA, Bimzelx, ILUMYA.
Industry payments across SC — which companies pay providers there.
